Dicerna Pharmaceuticals
Country
USA
Краткое название
Dicerna Pharmaceuticals Inc
Headquarters
480 Arsenal Street Building 1, Suite 120
Members of the board
Douglas Fambrough, Ph.D., Chief Executive Officer
Bob D. Brown, Ph.D., Chief Scientific Officer
David Cordo, Chief Financial Officer
Chris Cowles, Ph.D., Director, Intellectual Property
David Miller, Ph.D., Senior Director, Business Development
James B. Weissman, Chief Business Officer
Bob D. Brown, Ph.D., Chief Scientific Officer
David Cordo, Chief Financial Officer
Chris Cowles, Ph.D., Director, Intellectual Property
David Miller, Ph.D., Senior Director, Business Development
James B. Weissman, Chief Business Officer
Categories medicine
Oncology, Therapy
Stage of the project
Production
Disease
Metabolic syndrome
Current owners
Douglas Fambrough, Ph.D., Chief Executive Officer
Jonathan Fleming, Managing General Partner, Oxford Bioscience Partners
Brian Halak, Ph.D., Partner, Domain Associates
Stephen Hoffman, M.D., Ph.D., Managing Director, Skyline Ventures
Jim Jenson, Ph.D., Dicerna Co-Founder
Dennis Langer, M.D., J.D., Director, Dicerna Pharmaceuticals
Jonathan MacQuitty, Ph.D., Partner, Abingworth
David M. Madden, Chairman, Dicerna Pharmaceuticals
Jonathan Fleming, Managing General Partner, Oxford Bioscience Partners
Brian Halak, Ph.D., Partner, Domain Associates
Stephen Hoffman, M.D., Ph.D., Managing Director, Skyline Ventures
Jim Jenson, Ph.D., Dicerna Co-Founder
Dennis Langer, M.D., J.D., Director, Dicerna Pharmaceuticals
Jonathan MacQuitty, Ph.D., Partner, Abingworth
David M. Madden, Chairman, Dicerna Pharmaceuticals
Technology
Pharmaceuticals